VACCIN PCSK9 À BASE DE NOUVEAUX PEPTIDES
- 专利权人:
- Cadila Healthcare Limited
- 发明人:
- 申请号:
- EP18725910.6
- 公开号:
- EP3609532A1
- 申请日:
- 2018.04.12
- 申请国别(地区):
- EP
- 年份:
- 2020
- 代理人:
- 摘要:
- The present invention relates to novel short chain peptides of formula (I) which can be useful as a vaccine when in conjugation with suitable immunogenic carrier and suitable adjuvant. These are useful for the treatment for the PCSK9 mediated diseases.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- VACCIN PCSK9 A BASE DE NOUVEAUX PEPTIDES
- DOUBLE-STRANDED RIBONUCLEIC ACID FOR ADJUVANTS
- WÄSSRIGE ELEKTROLYT ENTHALTENDE ADJUVANT-ZUSAMMENSETZUNGEN, WIRKSTOFF ENTHALTENDE ZUSAMMENSETZUNGEN UND DEREN VERWENDUNG
- DOUBLE-STRANDED RIBONUCLEIC ACID FOR ADJUVANTS
- Double-stranded ribonucleic acid for adjuvants